Your session is about to expire
← Back to Search
Vibrotactile Stimulation
skin surface vibration for Parkinson's Disease
N/A
Waitlist Available
Led By Christopher W Hess, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-80 and able to provide informed consent.
Have a diagnosis of Parkinson's disease, essential tremor, or cervical dystonia made by a movement disorders specialist.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline up to immediately after the sham intervention
Awards & highlights
Study Summary
This study is evaluating whether vibration applied to the skin might improve motor control in people with movement disorders.
Eligible Conditions
- Parkinson's Disease
- Dystonia
- Essential Tremor
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline up to immediately after the sham intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline up to immediately after the sham intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quantitative Tremor Assessment
Secondary outcome measures
Functional Dexterity Task (FDT)
Reaction time task
Timed-up-and-go (TUG) gait task
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Vibrotactile Intermittent stimulationExperimental Treatment1 Intervention
Intermittent stimulation
Group II: Vibrotactile Continuous stimulationExperimental Treatment1 Intervention
Continuous stimulation
Group III: Vibrotactile ShamPlacebo Group1 Intervention
Sham stimulation
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,333 Previous Clinical Trials
714,551 Total Patients Enrolled
Parkinson's FoundationOTHER
11 Previous Clinical Trials
1,020,844 Total Patients Enrolled
Christopher W Hess, MDPrincipal InvestigatorNorman Fixel Institute for Neurological Diseases, University of Florida
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger